OncoSec Medical Incorporated (ONCSQ)

OncoSec Medical Income Statement

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jan 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019	Jul 31, 2018
Selling, General & Admin	10.88	11.19	15.28	18.31	11.97	18.69
Research & Development	21.77	25.82	34.1	25.1	18.45	17.42
Operating Expenses	32.65	37.01	49.38	43.41	30.42	36.11
Operating Income	-32.65	-37.01	-49.38	-43.41	-30.42	-36.11
Interest Expense	-0.05	-0.02	-0.02	-0.01	-0	-
Currency Exchange Gain (Loss)	-0.07	-0.51	-0.14	0.1	-0.28	-0.06
Other Non Operating Income (Expenses)	0.06	0.03	-0	0.19	0.44	-2.09
EBT Excluding Unusual Items	-32.72	-37.51	-49.54	-43.13	-30.26	-38.26
Gain (Loss) on Sale of Investments	-	-	-	-	-0.01	-
Gain (Loss) on Sale of Assets	-	-	-	-	-0	-0.88
Other Unusual Items	-	-	0.96	-	-	-
Pretax Income	-32.72	-37.51	-47.58	-43.13	-30.27	-39.14
Income Tax Expense	-3.33	-3.33	-2.41	-0.87	0	0
Net Income	-29.39	-34.18	-45.17	-42.25	-30.28	-39.14
Net Income to Common	-29.39	-34.18	-45.17	-42.25	-30.28	-39.14
Shares Outstanding (Basic)	2	2	1	1	0	0
Shares Outstanding (Diluted)	2	2	1	1	0	0
Shares Change (YoY)	13.17%	19.45%	99.00%	134.42%	75.79%	98.73%
EPS (Basic)	-14.77	-19.13	-30.20	-56.22	-94.43	-214.59
EPS (Diluted)	-14.77	-19.13	-30.20	-56.22	-94.43	-214.59
Free Cash Flow	-25.01	-32.38	-42.1	-33.15	-29.01	-23.29
Free Cash Flow Per Share	-12.57	-18.13	-28.15	-44.10	-90.50	-127.69
EBITDA	-32.4	-36.75	-49.14	-43.19	-30.17	-35.77
D&A For EBITDA	0.25	0.26	0.24	0.22	0.24	0.33
EBIT	-32.65	-37.01	-49.38	-43.41	-30.42	-36.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.